Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
CONFLICT OF INTEREST STATEMENT KES: None. ML: ML is an advisory board member for Octapharma, Dova, Principia, Rigel, Argenx, PDSA, 22qSociety and CdLS Foundation; a consultant for Novartis Dova, Principia, Argenx, Rigel, Sobi, Sanofi and Janssen; and has received research funding from FWGBD, PDSA, NIH, Sysmex, Novartis, Principia, Argenx, Dova, Octapharma and Sanofi.
CONFLICT OF INTEREST STATEMENT KES: None. ML: ML is an advisory board member for Octapharma, Dova, Principia, Rigel, Argenx, PDSA, 22qSociety and CdLS Foundation; a consultant for Novartis Dova, Principia, Argenx, Rigel, Sobi, Sanofi and Janssen; and has received research funding from FWGBD, PDSA, NIH, Sysmex, Novartis, Principia, Argenx, Dova, Octapharma and Sanofi.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
